Strong evidence shows heavy use of alcohol increases cardiovascular risk, but the American Heart Association is less clear ...

What’s driving this surge? Insmed revealed that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension (PAH) achieved..